- Workday surges 30%, software stocks rally, report: Silver Lake plans to acquire Workday
- According to documents from the U.S. Securities and Exchange Commission (SEC), as of June 30, Musk held 48.4% of SpaceX (SPCX.US) passive shares.
- Cadrenal Therapeutics Q2 net loss narrows 9.39% to $3.3 million
- M. Dias Branco board greenlights Q2 2026 financial report for CVM filing
- SusGlobal net loss widens to $1.81 million in Q2 2026; revenue falls to $17,331
- Genasys FY26 Q3 GAAP net loss narrows to $4.7 million; revenue falls to $7.3 million
- BNB Plus FY26 Q3 operating loss narrows 11% to $3.24 million; revenue more than triples to $605,306
- Matador Technologies reports C$1.1 million raised under at-the-market equity program in latest quarter
- Compass Minerals COO Brandon Risner files initial beneficial ownership statement
- Elastic schedules fiscal Q1 2027 earnings release and conference call
- Medical Properties Trust declares quarterly dividend of $0.09 a share
- Evolution PowerX cites Alberta market strength, turbine deployments as June 30, 2026 quarter revenue rises 36% to $8.8 million
- Rhinebeck Bancorp Q2 FY26 net income slips 3.7% to $2.6 million
- Farmer Mac names Nader Pasdar as chief business officer
- Sprott Physical Silver Trust management fees jump to $37.9 million in first half, interim report shows
- Kyntra Bio posts investor presentation highlighting FG-3246/FG-3180 Phase 2 program in prostate cancer
- Nektar Q2 FY26 net loss narrows to $40.62 million; revenue falls 9.35% to $10.1 million
- KinderCare Q2 FY26 turns to net loss of $8.8 million; revenue slips 0.4% to $697.5 million
- VSE senior management to attend Seaport Research Partners Annual Summer Investor Conference
- PepsiCo CEO Laguarta outlines 2030 growth strategy pillars in new “Food for Thought” interview
- Elutia Q2 FY26 net loss narrows 20.4% to $7.6 million; net sales fall 11.7% to $2.4 million
- Ocular Therapeutix grants new SVP Beth Rada options for 85,000 shares, 28,000 RSUs under inducement plan
- Globant Q2 IFRS diluted EPS swings to USD 0.04; revenue flat at USD 614.4 million
- VolitionRx Q2 FY26 operating loss narrows 34% to $4.2 million; operating expenses fall 32% on year
- B-Gaming shareholder Tabanelli to launch voluntary offer to swap Boldt shares for B-Gaming stock
- Bleichroeder Acquisition II swings to Q2 net income of $298,688; H1 net loss widens to $2.39 million
- Howard Hughes director Mary Ann Tighe reports disposal of shares worth $907,063.92
- York Space Systems Q2 FY26 net loss widens 62% to $(39.34) million; revenue rises 10% to $92.55 million
- ServiceTitan President Vahe Kuzoyan disposes of USD 9.44 million in common shares
- Xylem files Form 3 initial beneficial ownership statement for director D. Christian Koch
- Blaize Holdings 2Q Loss $28.8M >BZAI
- Lithium Americas raises $150 million via subordinated convertible debentures with YA II PN Ltd
- ONE Gas prices USD 375 million 5.45% senior notes due 2036 underwritten by BofA, RBC, Truist
- CPI Aerostructures returns to profit in Q2 FY26, net income $685,615; revenue rises 15.8% to $17.58 million
- Duke Energy prices USD 1.75 billion equity units backed by remarketable senior notes
- NYSE moves to delist SES AI warrants, halts trading immediately
- Birchtech publishes investor presentation on activated carbon technologies for mercury emissions and PFAS water treatment
- cbdMD FY26 Q3 operating loss widens to $1.13 million; net sales rise 20% to $5.6 million
- My Size FY26 Q2 net loss widens to $1.75 million; revenue rises to $3.07 million
- KinderCare Learning Sees 2026 Adj EPS 5c-Adj EPS 15c >KLC
- GrabAGun Q2 FY26 turns to net loss of $1.8 million; revenue rises 9.4% to $23.2 million
- Omeros appoints Tranceka Capital founder Joseph Schocken to board
- Matinas BioPharma FY26 Q2 net loss narrows to $3.25 million
- Xos Q2 FY26 operating loss widens to $7.9 million; revenue drops to $4.7 million
- XBP Global FY26 Q2 net loss narrows to USD 16.7 million; revenue drops 14% year-over-year to USD 191.3 million
- Nexentis Q2 FY26 net loss widens 154% to $11.16 million
- Unite Acquisition 1 net loss narrows 21% to $1.21 million in Q2 FY26
- Solarius Capital Acquisition swings to Q2 net income of $1.36 million; H1 net income rises to $2.75 million
- Oragenics Q2 net loss widens 11.3% to $2.53 million year over year
- Parker Hannifin draws USD 5.25 billion 364-day loan for Filtration Group deal
- GrabAGun Digital Holdings: Co-Founder and CFO Justin Hilty to Retire >PEW
- KinderCare Learning Sees 2026 Rev $2.66B-$2.70B >KLC
- Quantum BioPharma Q2 net loss narrows to USD 3.09 million; operating loss improves to USD 2.29 million
- Acurx net loss flat at $2.26 million in Q2 2026
- Soren Acquisition Q2 net income rises to $2.03 million
- Elite Pharmaceuticals Q1 FY27 operating income drops 65% to $7.5 million; revenue falls 20% to $32.4 million
- Illinois Tool Works prices $1.5 billion notes offering due 2029
- Yarrow Bioscience files amended 8-K report on merger exchange ratio update
- Blaize Holdings 2Q Rev $12M >BZAI
- Apple Showcases Texas Mac Mini Factory, New Manufacturing School -- WSJ
- Blaize Holdings Sees FY26 Rev $40M-$43M >BZAI
- KinderCare Learning 2Q Loss/Shr 7c >KLC
- KinderCare Learning 2Q Rev $697.52M >KLC
- Nektar Therapeutics 2Q Loss/Shr $1.23 >NKTR
- Nektar Therapeutics 2Q Rev $10.1M >NKTR
- Aethlon Medical 1Q Loss/Shr $4.02 >AEMD
- Heritage Global Q2 adjusted EBITDA misses as specialty lending exit weighs
- BRIEF-Cineverse Q1 Revenue USD 30.595 Million
- Bridgeline Q3 FY26 net loss narrows to $468,000; revenue rises 1.98% to $3.9 million
- Firy Q2 FY26 net loss widens to $24.5 million; revenue rises 23% year over year to $31 million
- Cibus Q2 FY26 net loss narrows 17% to $22.1 million; revenue rises 6.54% to $994,000
- MacroGenics Q2 FY26 turns to net income of $19.52 million; revenue more than doubled to $32.83 million
- Cineverse 1Q Loss/Shr 28c >CNVS
- CbdMD: Introducing a Zero-Proof Kava Beverage Under Oasis Brand >YCBD
- Caribou Biosciences Q2 FY26 GAAP net loss narrows to USD 24.3 million; revenue falls to USD 1.5 million
- PetMeds Q1 FY27 net loss narrows to $6.1 million; net sales fall 19.9% to $41 million
- Pinterest CEO Bill Ready speaks at Goldman Sachs Communacopia + Technology Conference
- Medpace director Cornelius P. McCarthy III sells 1,140 shares for $690,121.80
- Roadzen Q1 FY27 net loss widens to US $9.8 million; revenue rises 49% to US $16.2 million
- Invivyd Q2 FY26 net loss widens to $44.4 million; revenue rises 21% to $14.3 million
- Elutia secures $15 million loan financing from Avenue Capital Group
- SRX Global FY26 Q3 net loss from continuing operations narrows 40% year over year to $4.1 million; net sales rise 27% to $3.4 million
- Carpenter Technology director Ken Giacobbe files initial beneficial ownership statement
- 10x Genomics director John R. Stuelpnagel sells 20,000 shares worth $1.15 million
- SoundThinking GAAP net loss widens 52.24% to $4.8 million in Q2 FY26; revenue drops 8% to $23.9 million
- AMD SVP, GC & Corporate Secretary Ava Hahn disposes of 143 common shares worth $67,889.25
- Martin Marietta Raises Qtr Dividend to 84c Vs. 83c >MLM
- Martin Marietta Increases Qtrly Cash Div >MLM
- Arcadia Biosciences Q2 FY26 net loss widens 41% to $6.27 million; revenue slips 1% to $1.44 million
- MasterBrand EVP, COO Kurt Wanninger sells 50,000 shares for $461,065
- PEDEVCO Q2 FY26 returns to profit with net income USD 17.45 million; revenue rises 15% QoQ to USD 46.11 million
- Afya 2Q26 net income rises 14% to R$ 201.29 million; revenue increases 5.7% to R$ 972.1 million
- Digimarc Q2 FY26 net loss widens to $12.1 million; revenue falls to $7.4 million
- Beeline Q2 FY26 net loss narrows 24% vs. Q1 to $4 million; net revenue rises 57% year-over-year to $2.6 million
- Merlin Q2 FY26 GAAP net loss narrows to $58.4 million; revenue more than doubled to $2.2 million vs Q1 FY26
- StoneCo H1 net income from continuing operations climbs 103.01% to R$ 2.23 billion; revenue rises 4.43% to R$ 7.17 billion
- TechPrecision FY27 Q1 net loss narrows to $0.2 million; revenue rises 23% to $9.1 million
- Workhorse Q2 FY26 net loss widens to $20.2 million; revenue rises to $3.6 million
- 4D Molecular Therapeutics Q2 FY26 net loss widens to $72.94 million; revenue rises to $3.78 million
- Mad Money’s Jim Cramer Says These 6 AI Stocks are Primed to Surge
